CaƑete, Rb V.

HRN: 26-63-16  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/01/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
02/01/2025
02/07/2025
IVT
300mg
Q6
Pneumonia
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  PneumoniaEye, Ear, Nose, Throat, & Mouth    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: